Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

NCT00017082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: oxaliplatin

Sponsor

Prologue Research International